Neil Riordan PhD – Stem cell therapy for spinal cord injury (part 3 of 5)

Mesenchymal stem cell homing to tissue damage, umbilical cord stem cells historically used for anti-aging, mesenchymal stem cells role in immune system modulation, inflammation reduction and stimulating tissue regeneration, donor stem cell safety and testing, the role of HLA matching in donated umbilical cord-derived stem cells, umbilical cord blood safety data and historical use in [...]

Neil Riordan PhD – Stem cell therapy for spinal cord injury (part 2 of 5)

Case studies of spinal cord injury patients treated with CD34+ and mesenchymal stem cells harvested from human umbilical cord Wharton's jelly and cord blood, animal studies using mesenchymal stem cells, immunosuppression requirements in allogeneic stem cell treatments, intrathecal and intravenous administration of autologous bone marrow stem cells in spinal cord injury patients, and the role [...]

Contract’s end means changes for stem cell scene

In 2005 WiCell, a nonprofit organization affiliated with the University of Wisconsin was charged with creating and maintaining a national embryonic stem cell bank supported by the Federal Government.  At that time the 21 embryonic stem cell lines that were approved by former president George W. Bush's administration were made available for researchers.  The importance [...]

2010-03-03T19:20:58+00:00March 3rd, 2010|News, Stem Cells, Uncategorized|